Shree Ganesh Bio

{
  "main_header": {
    "sid": 999946,
    "name": "Shree Ganesh Bio",
    "stock_name": "Shree Ganesh Bio",
    "full_name": "Shree Ganesh Biotech India Ltd",
    "name_url": "stocks-analysis/shree-ganesh-bio",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.55",
    "chg": 0.01,
    "chgp": "1.85%",
    "dir": 1,
    "prev_price": "0.54",
    "mcapval": "22.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539470,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 61,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE051N01026",
    "curr_date": "Aug 04, 03:30 PM",
    "curr_time": "01:43 AM",
    "last_traded_at": "Aug 04, 03:30 PM IST",
    "bse_nse_vol": "3.87 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 04, 2026",
    "traded_date_str": "2026 08 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shree-ganesh-bio-999946-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Shree Ganesh Biotech India Q1 FY27: Mounting Losses Deepen Financial Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/shree-ganesh-biotech-india-q1-fy27-mounting-losses-deepen-financial-crisis-4136546",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ShreeGaneshBiot_quaterlyResult_4136546.png",
        "date": "2026-08-04 22:31:47",
        "description": "Shree Ganesh Biotech India Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹22.00 crores, continues to struggle with operational profitability as the company posted operating losses in Q1 FY27. Trading at ₹0.55 per share as of August 4, 2026, the stock has witnessed a precipitous decline of 30.38% over the past year, substantially underperforming the Sensex which declined 3.20% during the same period. With zero promoter holding, minimal institutional interest at 1.42%, and a concerning \"Strong Sell\" rating with a score of just 12 out of 100, the company faces mounting challenges in an already competitive pharmaceutical sector."
      },
      {
        "title": "Shree Ganesh Biotech India Ltd Slides to All-Time Low Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-biotech-india-ltd-hits-all-time-low-at-rs052-amid-bearish-market-trends-4128180",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ShreeGaneshBiot_priceRelatedfactors_4128180.png",
        "date": "2026-07-30 09:35:07",
        "description": "The stock of Shree Ganesh Biotech India Ltd has reached a fresh all-time low of Rs.0.52 on 30 Jul 2026, extending a multi-year decline that has seen the share price lose over 90% of its value in the past five years. Despite some recent upticks in profitability, the share price continues to reflect significant investor caution."
      },
      {
        "title": "When is the next results date for Shree Ganesh Biotech India Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-shree-ganesh-biotech-india-ltd-4116740",
        "imagepath": "",
        "date": "2026-07-22 23:17:34",
        "description": "The next results date for Shree Ganesh Biotech India Ltd is scheduled for August 4, 2026...."
      },
      {
        "title": "Markets Rise, But Shree Ganesh Biotech India Ltd Slides to All-Time Low Amid Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-biotech-india-ltd-hits-all-time-low-amidst-prolonged-downtrend-4108707",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ShreeGaneshBiot_priceRelatedfactors_4108707.png",
        "date": "2026-07-20 09:34:06",
        "description": "Despite a broadly positive market environment, Shree Ganesh Biotech India Ltd has continued its downward trajectory, hitting a fresh all-time low of ₹0.55 on 20 Jul 2026. This marks a significant milestone in the stock’s prolonged decline, underscoring persistent challenges that have yet to be fully addressed."
      },
      {
        "title": "Markets Rise, But Shree Ganesh Biotech India Ltd Slides to All-Time Low Amid Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-biotech-india-ltd-hits-all-time-low-amidst-prolonged-downtrend-4079033",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ShreeGaneshBiot_priceRelatedfactors_4079033.png",
        "date": "2026-06-30 13:42:54",
        "description": "Despite a broadly positive market environment, Shree Ganesh Biotech India Ltd has continued its downward trajectory, hitting a fresh all-time low of ₹0.56 on 30 Jun 2026. The stock’s persistent underperformance contrasts sharply with sector gains and broader indices, underscoring a complex interplay of valuation pressures and financial challenges."
      },
      {
        "title": "Shree Ganesh Biotech India Ltd Falls 4.92% Amid All-Time Low and Bearish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-biotech-india-ltd-falls-492-amid-all-time-low-and-bearish-momentum-4051151",
        "imagepath": "",
        "date": "2026-06-13 11:03:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>8 Jun:</strong> Stock opens at Rs.0.60, down 1.64% as Sensex falls 1.33%</p>\n                    <p><strong>9 Jun:</strong> Stock unchanged at Rs.0.60, Sensex rebounds +0.88%</p>\n                    <p><strong>10 Jun:</strong> Stock dips to Rs.0.59 (-1.67%), Sensex slips -0.61%</p>\n                    <p><strong>11 Jun:</strong> Stock hits 52-week low Rs.0.52 and all-time low Rs.0.58, down 3.39%, Sensex down 0.53%</p>\n                    <p><strong>12 Jun:</strong> Stock recovers slightly to Rs.0.58 (+1.75%), Sensex surges +2.20%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><di..."
      },
      {
        "title": "Shree Ganesh Biotech India Ltd Falls to 52-Week Low of Rs 0.52 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-biotech-india-ltd-falls-to-52-week-low-of-rs052-4046747",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ShreeGaneshBiot_priceRelatedfactors_4046747.png",
        "date": "2026-06-11 13:41:16",
        "description": "A sharp decline in the share price has dragged Shree Ganesh Biotech India Ltd to a fresh 52-week low of Rs 0.52 on 11 Jun 2026, marking a 34.83% drop over the past year and signalling sustained pressure on this micro-cap pharmaceutical stock."
      },
      {
        "title": "Shree Ganesh Biotech India Ltd Extends Losing Streak, Hits All-Time Low Amid Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-biotech-india-ltd-hits-all-time-low-amidst-prolonged-downtrend-4046738",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ShreeGaneshBiot_priceRelatedfactors_4046738.png",
        "date": "2026-06-11 13:12:48",
        "description": ""
      },
      {
        "title": "Are Shree Ganesh Biotech India Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-shree-ganesh-biotech-india-ltd-latest-results-good-or-bad-3993353",
        "imagepath": "",
        "date": "2026-05-15 19:26:09",
        "description": "Shree Ganesh Biotech India Ltd's latest financial results for the quarter ended March 2026 reflect significant operational challenges. The company reported a net profit loss of ₹0.15 crores, which represents a swing from a profit of ₹0.32 crores in the previous quarter, indicating a deterioration in profitability. This loss is accompanied by a deeply negative operating margin of -20.28%, which highlights ongoing issues in converting revenue into profit.\n\nDespite a sequential revenue increase of 202.86% to ₹2.12 crores from ₹0.70 crores in the previous quarter, the year-on-year revenue shows a decline of 29.57% from ₹3.01 crores in the same quarter last year. This volatility raises concerns about the sustainability of revenue growth and the company's ability to maintain a stable customer base.\n\nThe company's operational performance has been marked by persistent losses, with negative operating margins recorde..."
      }
    ],
    "total": 170,
    "sid": "999946",
    "stock_news_url": "https://www.marketsmojo.com/news/shree-ganesh-biotech-india-999946"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting.",
      "datetime": "21-Jul-2026",
      "details": "Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 4th August 2026 inter alia to consider following businesses: - 1.) To approve and take on record the Un-Audited Financial Results of the Company for the first quarter ended on 30th June 2026. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Jul-2026",
      "details": "PFA",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "12-Jun-2026",
      "details": "PFA",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Shree Ganesh Biotech India Ltd has announced <strong>1:10</strong> stock split, ex-date: 10 Feb 22",
          "dt": "2022-02-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shree Ganesh Biotech India Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 27 Apr 22",
          "dt": "2022-04-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Shree Ganesh Biotech India Q1 FY27: Mounting Losses Deepen Financial Crisis

2026-08-04 22:31:47

Shree Ganesh Biotech India Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹22.00 crores, continues to struggle with operational profitability as the company posted operating losses in Q1 FY27. Trading at ₹0.55 per share as of August 4, 2026, the stock has witnessed a precipitous decline of 30.38% over the past year, substantially underperforming the Sensex which declined 3.20% during the same period. With zero promoter holding, minimal institutional interest at 1.42%, and a concerning "Strong Sell" rating with a score of just 12 out of 100, the company faces mounting challenges in an already competitive pharmaceutical sector.

Read full news article

Shree Ganesh Biotech India Ltd Slides to All-Time Low Amid Prolonged Downtrend

2026-07-30 09:35:07

The stock of Shree Ganesh Biotech India Ltd has reached a fresh all-time low of Rs.0.52 on 30 Jul 2026, extending a multi-year decline that has seen the share price lose over 90% of its value in the past five years. Despite some recent upticks in profitability, the share price continues to reflect significant investor caution.

Read full news article

When is the next results date for Shree Ganesh Biotech India Ltd?

2026-07-22 23:17:34

The next results date for Shree Ganesh Biotech India Ltd is scheduled for August 4, 2026....

Read full news article

Markets Rise, But Shree Ganesh Biotech India Ltd Slides to All-Time Low Amid Stock-Specific Sell-Off

2026-07-20 09:34:06

Despite a broadly positive market environment, Shree Ganesh Biotech India Ltd has continued its downward trajectory, hitting a fresh all-time low of ₹0.55 on 20 Jul 2026. This marks a significant milestone in the stock’s prolonged decline, underscoring persistent challenges that have yet to be fully addressed.

Read full news article

Markets Rise, But Shree Ganesh Biotech India Ltd Slides to All-Time Low Amid Stock-Specific Sell-Off

2026-06-30 13:42:54

Despite a broadly positive market environment, Shree Ganesh Biotech India Ltd has continued its downward trajectory, hitting a fresh all-time low of ₹0.56 on 30 Jun 2026. The stock’s persistent underperformance contrasts sharply with sector gains and broader indices, underscoring a complex interplay of valuation pressures and financial challenges.

Read full news article

Shree Ganesh Biotech India Ltd Falls 4.92% Amid All-Time Low and Bearish Momentum

2026-06-13 11:03:08

Key Events This Week

8 Jun: Stock opens at Rs.0.60, down 1.64% as Sensex falls 1.33%

9 Jun: Stock unchanged at Rs.0.60, Sensex rebounds +0.88%

10 Jun: Stock dips to Rs.0.59 (-1.67%), Sensex slips -0.61%

11 Jun: Stock hits 52-week low Rs.0.52 and all-time low Rs.0.58, down 3.39%, Sensex down 0.53%

12 Jun: Stock recovers slightly to Rs.0.58 (+1.75%), Sensex surges +2.20%

Week Open

Read full news article

Shree Ganesh Biotech India Ltd Falls to 52-Week Low of Rs 0.52 as Sell-Off Deepens

2026-06-11 13:41:16

A sharp decline in the share price has dragged Shree Ganesh Biotech India Ltd to a fresh 52-week low of Rs 0.52 on 11 Jun 2026, marking a 34.83% drop over the past year and signalling sustained pressure on this micro-cap pharmaceutical stock.

Read full news article

Shree Ganesh Biotech India Ltd Extends Losing Streak, Hits All-Time Low Amid Financial Struggles

2026-06-11 13:12:48

Read full news article

Are Shree Ganesh Biotech India Ltd latest results good or bad?

2026-05-15 19:26:09

Shree Ganesh Biotech India Ltd's latest financial results for the quarter ended March 2026 reflect significant operational challenges. The company reported a net profit loss of ₹0.15 crores, which represents a swing from a profit of ₹0.32 crores in the previous quarter, indicating a deterioration in profitability. This loss is accompanied by a deeply negative operating margin of -20.28%, which highlights ongoing issues in converting revenue into profit. Despite a sequential revenue increase of 202.86% to ₹2.12 crores from ₹0.70 crores in the previous quarter, the year-on-year revenue shows a decline of 29.57% from ₹3.01 crores in the same quarter last year. This volatility raises concerns about the sustainability of revenue growth and the company's ability to maintain a stable customer base. The company's operational performance has been marked by persistent losses, with negative operating margins recorde...

Read full news article

View All News